PFO
DTIL icon

Pathstone Family Office’s Precision BioSciences DTIL Stock Holding History

Pathstone Family Office’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$9.03K Buy
+882
New +$13.6K ﹤0.01% 1655
2020
Q3 		– Sell
-152
Closed -$38K – 845
2020
Q2 		$38K Hold
152
– – ﹤0.01% 346
2020
Q1 		$27K Buy
+152
New +$39.8K ﹤0.01% 384

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pathstone Family Office's DTIL Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Precision BioSciences (DTIL) in Q3 2023: 882 shares worth $9.03K. The stake represents ﹤0.01% of the portfolio and ranks #1655 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in DTIL as recently as Q2 2020.

Pathstone Family Office first reported a position in DTIL in Q1 2020 and has held it in 3 quarters since. The position peaked at $38K in Q2 2020. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

  • Pathstone Family Office held 882 shares of Precision BioSciences worth $9.03K as of Q3 2023.
  • Precision BioSciences was a new Pathstone Family Office position in Q3 2023.
  • Precision BioSciences made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1655 holding.
  • Pathstone Family Office first reported a position in Precision BioSciences in Q1 2020 and has held it in 3 quarters since.
  • Pathstone Family Office's Precision BioSciences position peaked at $38K in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.